Projects funded by the NCN
NK cells with inducible expression of CAR as novel immunotherapy increasing the efficacy of monoclonal antibodies.
2016/23/B/NZ5/02622
Keywords:
NK cells chimeric antigen receptors anti-CD20 therapeutic antibodies
Descriptors:
- NZ5_7: Human disease treatment
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Warszawski Uniwersytet Medyczny, I Wydział Lekarski
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 4
Call: OPUS 12 - announced on 2016-09-15
Amount awarded: 1 651 770 PLN
Project start date (Y-m-d): 2017-08-01
Project end date (Y-m-d): 2022-07-31
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.